Raffaele Gimigliano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Raffaele Gimigliano has a total of 169 co-authors. Here are the top co-authors by number of shared publications:
- Giovanni Iolascon
Department of Medical and Surgical Specialties and Dentistry, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
27 shared publications Francesca Gimigliano
13 shared publications- Antimo Moretti
University of Campania “Luigi Vanvitelli
7 shared publications - Prisco Piscitelli
Department of Experimental Medicine, University of Salento, 73100 Lecce, Italy
7 shared publications F Gimigliano
5 shared publicationsF. Gimigliano
Department of Medical and Surgical Specialties and Dentistry, Second University of Naples, Naples, Italy
5 shared publications
Latest Publications
- 5 September 2017
- Published by Springer Nature
- p. 407-419
Rehabilitation of Older Patients with Mental Disorders
- 5 September 2017
- Published by Springer Nature
- p. 407-419
Rehabilitation of Older Patients with Mental Disorders
- 21 April 2016
- Published by Bioscientifica in Bone Abstracts
Effects of calcifediol versus cholecalciferol on 25(OH)D3 serum levels, appendicular muscle strength, and physical performance in post-menopausal women
Background: Post-menopausal women generally present reduced serum levels of vitamin D, reduced VDR expression in skeletal muscle cells, and a gradual loss of muscle mass and muscle function. The relationship between serum 25-hydroxyvitamin D [25(OH)D3] levels and muscle strength has been extensively investigated, even though there is no agreement in literature. Therefore, aim of our study was to evaluate the effects of vitamin D on 25(OH)D3 levels, muscle strength, and physical performance in post-menopausal women, comparing calcifediol and cholecalciferol. Material and methods: In this prospective study we included postmenopausal women, dividing them into two groups, according to the prescription performed (calcifediol or cholecalciferol). We evaluated at the baseline (T0) and after 6 months (T1): serum levels of 25(OH)D3, appendicular muscle strength, using the Hand Grip Strength Test (HGS) and the Knee Extensor Strength Test (KES), and physical performance, using the Short Physical Performance Battery (SPPB). Results: We evaluated 205 post-menopausal women, mean aged 6928±916 years, 103 treated with calcifediol and 102 with cholecalciferol. In Table 1 we showed the results. Table 1 Outcome measures assessed at the baseline and after 6 months of vitamin D supplementation. Calcifediol T0 (n=103) Calcifediol T1 (n=103) P values 25(OH)D3 (ng/ml) 31.74±13.03 51.80±19.85 n=102) Cholecalciferol T1 (n=102) P values 25(OH)D3 (ng/ml) 35.15±11.57 40.28±13.04 0.118 HGS (kg) 15,36±6.06 16.38±5.14 0.257 KES (kg) 12.12±5.74 12.58±5.67 0.627 SPPB 7.81±3.66 8.02±3.41 0.638 Results are expressed as means±S.D. Analysis was performed using a paired t-test. Conclusions: Our results showed that post-menopausal women treated with calcifediol had significant improvements in serum levels of 25(OH)D3, muscle strength, and physical performance.
- 21 April 2016
- Published by Bioscientifica in Bone Abstracts
Effects of calcifediol versus cholecalciferol on 25(OH)D3 serum levels, appendicular muscle strength, and physical performance in post-menopausal women
Background: Post-menopausal women generally present reduced serum levels of vitamin D, reduced VDR expression in skeletal muscle cells, and a gradual loss of muscle mass and muscle function. The relationship between serum 25-hydroxyvitamin D [25(OH)D3] levels and muscle strength has been extensively investigated, even though there is no agreement in literature. Therefore, aim of our study was to evaluate the effects of vitamin D on 25(OH)D3 levels, muscle strength, and physical performance in post-menopausal women, comparing calcifediol and cholecalciferol. Material and methods: In this prospective study we included postmenopausal women, dividing them into two groups, according to the prescription performed (calcifediol or cholecalciferol). We evaluated at the baseline (T0) and after 6 months (T1): serum levels of 25(OH)D3, appendicular muscle strength, using the Hand Grip Strength Test (HGS) and the Knee Extensor Strength Test (KES), and physical performance, using the Short Physical Performance Battery (SPPB). Results: We evaluated 205 post-menopausal women, mean aged 6928±916 years, 103 treated with calcifediol and 102 with cholecalciferol. In Table 1 we showed the results. Table 1 Outcome measures assessed at the baseline and after 6 months of vitamin D supplementation. Calcifediol T0 (n=103) Calcifediol T1 (n=103) P values 25(OH)D3 (ng/ml) 31.74±13.03 51.80±19.85 n=102) Cholecalciferol T1 (n=102) P values 25(OH)D3 (ng/ml) 35.15±11.57 40.28±13.04 0.118 HGS (kg) 15,36±6.06 16.38±5.14 0.257 KES (kg) 12.12±5.74 12.58±5.67 0.627 SPPB 7.81±3.66 8.02±3.41 0.638 Results are expressed as means±S.D. Analysis was performed using a paired t-test. Conclusions: Our results showed that post-menopausal women treated with calcifediol had significant improvements in serum levels of 25(OH)D3, muscle strength, and physical performance.
- 26 July 2015
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 27 (S1) , 3-9
Back pain-related disability and quality of life in patients affected by vertebral fractures: data from baseline characteristics of population enrolled in Denosumab In Real Practice (DIRP)
Background Spine fragility fractures lead to a significant acute and/or chronic pain and worsening of quality of life. Denosumab is effective in reducing the risk of new vertebral fractures, but its effectiveness on pain relief and improvement of the quality of life in patients with spine fractures are not well known. Aim The aim of this paper is to describe the baseline demographic and clinical characteristics, back pain-related disability and quality of life of the Denosumab In Real Practice (DIRP) study population. Methods DIRP is a multicenter prospective observational study evaluating the effectiveness of denosumab in reducing back pain-related disability and Health-Related Quality of Life (HRQoL) of women with postmenopausal osteoporosis who had already experienced at least one vertebral fragility fracture. Our evaluation protocol includes history of fractures, Spine Pain Index (SPI), HRQoL, bone mineral density (BMD) and radiological assessment of vertebral fragility fractures. Results Two hundred and twenty-three post-menopausal women, who received a prescription for denosumab, were enrolled. The mean SPI score was 58.6 ± 21.4 SD, and 187 (83.86 %) women experienced a moderate–severe pain. The mean HRQoL health state value was 0.54 ± 0.27 SD using EQ-5D index, whereas the mean Physical and Mental Health Composite Scale scores derived from the SF-12 were 31.06 ± 7.77 SD and 39.20 ± 11.03 SD. Discussion and conclusions Baseline characteristics of DIRP study cohort indicate that patients who received a prescription of denosumab in Campania region are affected by severe osteoporosis with highly prevalent vertebral fractures, disabling back pain and poor health-related quality of life. This is in contradiction with what it is expected by a front-line drug for osteoporosis.
- 26 July 2015
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 27 (S1) , 3-9
Back pain-related disability and quality of life in patients affected by vertebral fractures: data from baseline characteristics of population enrolled in Denosumab In Real Practice (DIRP)
Background Spine fragility fractures lead to a significant acute and/or chronic pain and worsening of quality of life. Denosumab is effective in reducing the risk of new vertebral fractures, but its effectiveness on pain relief and improvement of the quality of life in patients with spine fractures are not well known. Aim The aim of this paper is to describe the baseline demographic and clinical characteristics, back pain-related disability and quality of life of the Denosumab In Real Practice (DIRP) study population. Methods DIRP is a multicenter prospective observational study evaluating the effectiveness of denosumab in reducing back pain-related disability and Health-Related Quality of Life (HRQoL) of women with postmenopausal osteoporosis who had already experienced at least one vertebral fragility fracture. Our evaluation protocol includes history of fractures, Spine Pain Index (SPI), HRQoL, bone mineral density (BMD) and radiological assessment of vertebral fragility fractures. Results Two hundred and twenty-three post-menopausal women, who received a prescription for denosumab, were enrolled. The mean SPI score was 58.6 ± 21.4 SD, and 187 (83.86 %) women experienced a moderate–severe pain. The mean HRQoL health state value was 0.54 ± 0.27 SD using EQ-5D index, whereas the mean Physical and Mental Health Composite Scale scores derived from the SF-12 were 31.06 ± 7.77 SD and 39.20 ± 11.03 SD. Discussion and conclusions Baseline characteristics of DIRP study cohort indicate that patients who received a prescription of denosumab in Campania region are affected by severe osteoporosis with highly prevalent vertebral fractures, disabling back pain and poor health-related quality of life. This is in contradiction with what it is expected by a front-line drug for osteoporosis.
- 17 July 2015
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 27 (S1) , 23-30
Hypovitaminosis D is associated with a reduction in upper and lower limb muscle strength and physical performance in post-menopausal women: a retrospective study
Elderly people experience a gradual loss of muscle strength and a reduction of serum levels of vitamin D and of vitamin D receptor expression in skeletal muscle cells. The aim of our study was to evaluate the association among serum levels of 25-hydroxy-vitamin D [25(OH)D3], muscle strength, and physical performance in post-menopausal women. In our retrospective case–control study, we analyzed data from medical records of post-menopausal women aged ≥50 years. We compared subjects with hypovitaminosis D [25(OH)D3 3 ≥30 ng/ml]. Outcome measures were: Hand Grip Strength Test (HGS) and Knee Extension Strength Test (KES) to evaluate upper and lower limb muscle strength, respectively; Short Physical Performance Battery (SPPB) and usual 4-m gait speed (4MGS) to evaluate physical performance. We examined 80 patients (mean aged 65.92 ± 7.69 years): forty-six subjects with hypovitaminosis D (mean aged 66.09 ± 7.71 years) and 34 with normal levels of vitamin D (mean aged 65.71 ± 7.78 years). There was a statistically significant difference between hypovitaminosis D group and subjects with normal levels of vitamin D in HGS (12.13 ± 4.34 vs. 19.14 ± 5.59; p < 0.001), KES (11.99 ± 4.04 vs. 16.98 ± 8.43; p = 0.003), SPPB score [8 (5.75-10.25) vs. 12 (10-12); p < 0.001], and proportion of patients with usual 4MGS ≤ 0.8 m/s [29 (63.0 %) vs. 9 (26.5 %); p = 0.002]. In literature, there is no agreement on the association among serum vitamin D levels and muscle function. Our data showed that post-menopausal women with hypovitaminosis D had worse upper and lower limb muscle strength and physical performance than subjects with normal levels of 25(OH)D3. Our results support the hypothesis that there is a significant positive association among serum 25(OH)D3 levels and upper and lower limb muscle functioning.
- 17 July 2015
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 27 (S1) , 23-30
Hypovitaminosis D is associated with a reduction in upper and lower limb muscle strength and physical performance in post-menopausal women: a retrospective study
Elderly people experience a gradual loss of muscle strength and a reduction of serum levels of vitamin D and of vitamin D receptor expression in skeletal muscle cells. The aim of our study was to evaluate the association among serum levels of 25-hydroxy-vitamin D [25(OH)D3], muscle strength, and physical performance in post-menopausal women. In our retrospective case–control study, we analyzed data from medical records of post-menopausal women aged ≥50 years. We compared subjects with hypovitaminosis D [25(OH)D3 3 ≥30 ng/ml]. Outcome measures were: Hand Grip Strength Test (HGS) and Knee Extension Strength Test (KES) to evaluate upper and lower limb muscle strength, respectively; Short Physical Performance Battery (SPPB) and usual 4-m gait speed (4MGS) to evaluate physical performance. We examined 80 patients (mean aged 65.92 ± 7.69 years): forty-six subjects with hypovitaminosis D (mean aged 66.09 ± 7.71 years) and 34 with normal levels of vitamin D (mean aged 65.71 ± 7.78 years). There was a statistically significant difference between hypovitaminosis D group and subjects with normal levels of vitamin D in HGS (12.13 ± 4.34 vs. 19.14 ± 5.59; p < 0.001), KES (11.99 ± 4.04 vs. 16.98 ± 8.43; p = 0.003), SPPB score [8 (5.75-10.25) vs. 12 (10-12); p < 0.001], and proportion of patients with usual 4MGS ≤ 0.8 m/s [29 (63.0 %) vs. 9 (26.5 %); p = 0.002]. In literature, there is no agreement on the association among serum vitamin D levels and muscle function. Our data showed that post-menopausal women with hypovitaminosis D had worse upper and lower limb muscle strength and physical performance than subjects with normal levels of 25(OH)D3. Our results support the hypothesis that there is a significant positive association among serum 25(OH)D3 levels and upper and lower limb muscle functioning.
- 21 May 2015
- Vol. 51 (5) , 529-38
Classification of functioning and assessment of fracture risk of a large Italian osteoporotic population. The Physiatric Approach To Osteoporosis project.
Osteoporosis is a skeletal disorder characterized by compromised bone strength predisposing to an increased risk of fracture. Osteoporotic fractures cause significant morbidity, disability, and decrease in quality of life. The aims of the Physiatric Approach To Osteoporosis (PATO) project were to classify osteoporotic patients with or without fragility fractures, using the Brief ICF (International Classification of Functioning, Disability and Health) Core Set for Osteoporosis and to calculate the fracture risk with the WHO FRAX® (World Health Organization Fracture Risk Assessment Tool) algorithm. Cross-sectional survey. Seventy-nine Italian Rehabilitation Services distributed throughout Italy. Osteoporotic patients. Each physiatrist involved in the survey was asked systematically to record demographic data, presence of fragility fractures, anamnestic risk factors included in the FRAX® Assessment Tool, ICF categories as they are listed in the Brief ICF Core Set for Osteoporosis, and treatment data of 100 osteoporotic patients (50 with at least a clinical fragility fracture and 50 without). In accordance with the FRAX® algorithm, the 35.22% of the interviewed osteoporotic patients had a FRAX® MAJ≥20.00 and the 70.32% had a FRAX® HIP≥3.00. The most commonly impaired ICF categories were the sensation of pain for the body functions, the structure of the trunk for body structures, lifting and carrying objects for the domain of activities and participation, and products or substances for personal consumption for the environmental factors. The FRAX® Assessment tool has been recognized as useful to identify people at high risk of fracture and the Brief ICF Core Set seems to be an important framework to be followed when dealing with osteoporotic patients in an outpatient setting or for clinical studies. Osteoporosis is well recognized as a disabling disease, posing a significant challenge for the society, therefore physiatrists should always be involved, from prevention to treatment.
- 21 May 2015
- Vol. 51 (5) , 529-38
Classification of functioning and assessment of fracture risk of a large Italian osteoporotic population. The Physiatric Approach To Osteoporosis project.
Osteoporosis is a skeletal disorder characterized by compromised bone strength predisposing to an increased risk of fracture. Osteoporotic fractures cause significant morbidity, disability, and decrease in quality of life. The aims of the Physiatric Approach To Osteoporosis (PATO) project were to classify osteoporotic patients with or without fragility fractures, using the Brief ICF (International Classification of Functioning, Disability and Health) Core Set for Osteoporosis and to calculate the fracture risk with the WHO FRAX® (World Health Organization Fracture Risk Assessment Tool) algorithm. Cross-sectional survey. Seventy-nine Italian Rehabilitation Services distributed throughout Italy. Osteoporotic patients. Each physiatrist involved in the survey was asked systematically to record demographic data, presence of fragility fractures, anamnestic risk factors included in the FRAX® Assessment Tool, ICF categories as they are listed in the Brief ICF Core Set for Osteoporosis, and treatment data of 100 osteoporotic patients (50 with at least a clinical fragility fracture and 50 without). In accordance with the FRAX® algorithm, the 35.22% of the interviewed osteoporotic patients had a FRAX® MAJ≥20.00 and the 70.32% had a FRAX® HIP≥3.00. The most commonly impaired ICF categories were the sensation of pain for the body functions, the structure of the trunk for body structures, lifting and carrying objects for the domain of activities and participation, and products or substances for personal consumption for the environmental factors. The FRAX® Assessment tool has been recognized as useful to identify people at high risk of fracture and the Brief ICF Core Set seems to be an important framework to be followed when dealing with osteoporotic patients in an outpatient setting or for clinical studies. Osteoporosis is well recognized as a disabling disease, posing a significant challenge for the society, therefore physiatrists should always be involved, from prevention to treatment.
- 20 May 2015
- Vol. 51 (5) , 513-20
Effects of focal muscle vibration on physical functioning in patients with knee osteoarthritis: a randomized controlled trial.
Knee osteoarthritis (OA) is a chronic condition characterized by pain, stiffness and functional limitations. According to the OsteoArthritis Research Society International (OARSI) recommendations, patients with knee OA should undertake regular quadriceps muscle strengthening exercises. Whole body vibration (WBV) proved its effectiveness in strengthening of the quadriceps muscles and improving balance in chronic knee OA patients. To date, there are no published studies that investigated the effects of focal muscle vibration (FMV) in these patients. The aim of the present study was to evaluate the effects of FMV on physical functioning in patients with symptomatic knee OA. Randomized controlled trial. Outpatient clinic, University Hospital. Men and women aged 60 years or older with radiographic diagnosis of mild to moderate monolateral knee OA (Kellgren-Lawrence grade II or III) and chronic knee pain. Patients were randomized in two groups (treatment group and placebo control group). The treatment group received FMV treatment, according to the "repeated muscle vibration" protocol. The control group received a sham treatment. The primary outcome measure was the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Secondary outcome measures were the Short Physical Performance Battery (SPPB) and the Performance-Oriented Mobility Assessment (POMA). Follow up evaluations were done at 3 and 6 months. Fifty patients were recruited and randomly assigned to either the study or control group. There was a statistical significant difference between the two groups both for primary (WOMAC) and secondary (SPPB and POMA) outcomes. In this study, FMV therapy has proven to be effective and safe in improving functioning of patients affected by mild to moderate chronic knee OA. The use of FMV therapy might be an additional and safe tool in the conservative management of knee OA.
- 20 May 2015
- Vol. 51 (5) , 513-20
Effects of focal muscle vibration on physical functioning in patients with knee osteoarthritis: a randomized controlled trial.
Knee osteoarthritis (OA) is a chronic condition characterized by pain, stiffness and functional limitations. According to the OsteoArthritis Research Society International (OARSI) recommendations, patients with knee OA should undertake regular quadriceps muscle strengthening exercises. Whole body vibration (WBV) proved its effectiveness in strengthening of the quadriceps muscles and improving balance in chronic knee OA patients. To date, there are no published studies that investigated the effects of focal muscle vibration (FMV) in these patients. The aim of the present study was to evaluate the effects of FMV on physical functioning in patients with symptomatic knee OA. Randomized controlled trial. Outpatient clinic, University Hospital. Men and women aged 60 years or older with radiographic diagnosis of mild to moderate monolateral knee OA (Kellgren-Lawrence grade II or III) and chronic knee pain. Patients were randomized in two groups (treatment group and placebo control group). The treatment group received FMV treatment, according to the "repeated muscle vibration" protocol. The control group received a sham treatment. The primary outcome measure was the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Secondary outcome measures were the Short Physical Performance Battery (SPPB) and the Performance-Oriented Mobility Assessment (POMA). Follow up evaluations were done at 3 and 6 months. Fifty patients were recruited and randomly assigned to either the study or control group. There was a statistical significant difference between the two groups both for primary (WOMAC) and secondary (SPPB and POMA) outcomes. In this study, FMV therapy has proven to be effective and safe in improving functioning of patients affected by mild to moderate chronic knee OA. The use of FMV therapy might be an additional and safe tool in the conservative management of knee OA.
- 7 July 2014
- Vol. 54 (6) , 757-64
Whole body vibration in sport: a critical review.
Whole body vibration training is a recent area of study in athletic conditioning, health and rehabilitation. This paper provides a review of the effectiveness of this type of training in sport. A search was conducted across several electronic databases and studies on effects of whole body vibration training on sport performance were reviewed. Thirteen articles were included in the final analysis. The following variables were considered: participants investigated (sex and age), characteristics of the vibration (frequency and amplitude), training (type of sport, exposure time and intensity, tests used, type of study, effects examined and results obtained). This review considers proposed neural mechanisms and identifies studies that have demonstrated the effectiveness of WBV in sports. It considers where WBV might act and suggests that vibration can be an effective training stimulus. Future studies should focus on evaluating the long-term effects of vibration training and identify optimum frequency and amplitude, improve strength and muscular performance.
- 7 July 2014
- Vol. 54 (6) , 757-64
Whole body vibration in sport: a critical review.
Whole body vibration training is a recent area of study in athletic conditioning, health and rehabilitation. This paper provides a review of the effectiveness of this type of training in sport. A search was conducted across several electronic databases and studies on effects of whole body vibration training on sport performance were reviewed. Thirteen articles were included in the final analysis. The following variables were considered: participants investigated (sex and age), characteristics of the vibration (frequency and amplitude), training (type of sport, exposure time and intensity, tests used, type of study, effects examined and results obtained). This review considers proposed neural mechanisms and identifies studies that have demonstrated the effectiveness of WBV in sports. It considers where WBV might act and suggests that vibration can be an effective training stimulus. Future studies should focus on evaluating the long-term effects of vibration training and identify optimum frequency and amplitude, improve strength and muscular performance.
- 18 September 2013
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 25 (S1) , 109-111
Rehabilitative approach in patients with vertebral fragility fracture
Osteoporosis is a skeleton disease characterized by low bone mineral density and deterioration of bone tissue, resulting in an increased risk of fragility fracture. Osteoporotic vertebral fractures are recognized as a significant health problem particularly in older people with an impact on the quality of life, mobility and mortality. A well-timed diagnosis and treatment is necessary in preventing further vertebral fracture and their consequences. Exercise alone or as part of physical therapy management is often recommended as a non-pharmacological intervention. The exercise protocols, designed specifically for individuals with vertebral fracture, should include postural correction, trunk and lower extremity muscle strengthening, balance exercises and falls prevention program. The aim of this short communication is to examine the rationale of a rehabilitation protocol after a vertebral fracture.
- 18 September 2013
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 25 (S1) , 109-111
Rehabilitative approach in patients with vertebral fragility fracture
Osteoporosis is a skeleton disease characterized by low bone mineral density and deterioration of bone tissue, resulting in an increased risk of fragility fracture. Osteoporotic vertebral fractures are recognized as a significant health problem particularly in older people with an impact on the quality of life, mobility and mortality. A well-timed diagnosis and treatment is necessary in preventing further vertebral fracture and their consequences. Exercise alone or as part of physical therapy management is often recommended as a non-pharmacological intervention. The exercise protocols, designed specifically for individuals with vertebral fracture, should include postural correction, trunk and lower extremity muscle strengthening, balance exercises and falls prevention program. The aim of this short communication is to examine the rationale of a rehabilitation protocol after a vertebral fracture.
- 18 September 2013
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 25 (S1) , 129-131
Sarcopenia in women with vertebral fragility fractures
- 18 September 2013
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 25 (S1) , 129-131
Sarcopenia in women with vertebral fragility fractures